Filter
90
Text search:
hydroxychloroquine
Featured
Recommendations
22
New Publications
10
Language
Document type
Guidelines
53
Studies & Reports
16
No document type
8
Manuals
3
Resource Platforms
3
Fact sheets
3
Strategic & Response Plan
2
Training Material
1
Infographics
1
Countries / Regions
Brazil
11
India
8
Latin America and the Carribbean
5
Russia
5
Germany
3
Guinea-Bissau
2
Ethiopia
2
Kenya
2
South Africa
2
Mozambique
2
Angola
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Global
2
Nigeria
1
South Sudan
1
Syria
1
Bangladesh
1
Central African Republic
1
Argentina
1
Namibia
1
Peru
1
North Macedonia
1
Serbia
1
Ukraine
1
Ecuador
1
Bolivia
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Bhutan
1
Armenia
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Mauritius
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
52
Clinical Guidelines
7
Key Resources
2
Annual Report MEDBOX
1
Public Health
1
Toolboxes
COVID-19
61
Pharmacy
8
NTDs
4
Malaria
3
Rapid Response
2
Polio
1
Conflict
1
Mental Health
1
AMR
1
NCDs
1
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have s
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public
...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
This table summarises the drugs used for malaria prevention, including adult and paediatric dosages, timing and special considerations. The medications listed are atovaquone/proguanil, chloroquine, doxycycline, hydroxychloroquine, mefloquine, primaq
...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-
...
CDC Afrique est préoccupé par les informations inexactes distribués par les médias traditionnels et sociaux en ce qui concerne la prévention et le traitement des maladies nouvelles coronavirus (Covid-19).
Sur la base d’un examen des preuves et de l’évaluation d’experts, le CDC Afrique r
...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Updated Treatment Guidelines
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By
...
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I
...
Острая респираторная вирусная инфекция (ОРВИ) – острое
инфекционное заболевание респираторного тракта, проявляющееся
воспалением верхних дыхательных путей, в б
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe
...
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
Here you can download infographics and posters
